ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0022

Evaluation of the Online Glomerular Disease Fellowship Program Using the Kirkpatrick Model

Session Information

Category: Educational Research

  • 1000 Educational Research

Authors

  • Norouzi, Sayna, Loma Linda University, Loma Linda, California, United States
  • Pitogo, Rica Mae, GlomCon Foundation, San Francisco, California, United States
  • Seethapathy, Harish Shanthanu, Massachusetts General Hospital, Boston, Massachusetts, United States
  • Robson, Kate, Monash University, Melbourne, Victoria, Australia
  • Poyan Mehr, Ali, GlomCon Foundation, San Francisco, California, United States
  • Loo, Lawrence K., Loma Linda University, Loma Linda, California, United States

Group or Team Name

  • On behalf of the GlomCon Fellowship Team.
Background

Since its inception in 2020, GlomCon's online glomerular disease fellowship program has seen significant growth and engagement among nephrologists. We evaluated the educational effectiveness of this program and its impact on clinical practice among the fellowship graduates.

Methods

This preliminary report evaluates the effectiveness of the Online Glomerular Disease Fellowship Program using the Kirkpatrick model to assess levels of educational outcomes – (1) participants’ reactions, (2) learning outcomes, (3) behavioral changes, and (4) organizational impact. A 24-item survey was distributed to 364 graduates who completed the fellowship between 2020 and 2023, assessing its content, instructional quality, impact and overall effectiveness.

Results

Of the 364 graduates surveyed, 187 (51.4%) responded. Participants came from over 150 different institutions from around the globe.
Level 1: Learner satisfaction ratings were exceptionally high. Participants were “Very Satisfied” or “Moderately Satisfied” with the course content (91.4%), quality of instructors and facilitators (90.9%), flexibility of the online format (86.6%), and networking opportunities (77.5%).
Level 2: Thematic analysis demonstrated key areas of learning included "Interpreting renal pathology” and "Pathological-clinical correlation".
Level 3: 82.4% of respondents reported implementing changes in their clinical practices after completing the fellowship, particularly regarding "Renal Pathology & Biopsy Interpretation" and increased adherence to "Evidence-Based Practice."
Level 4: Participants reported improvements in patient outcomes as a result of the enhanced training (78.1%), implementation of new protocols or guidelines within their institutions (44.4%), and 23.5% started a dedicated glomerular disease clinic or joined an existing one in their institution since graduating from the program.

Conclusion

This preliminary report demonstrate that the GlomCon Glomerular Disease Fellowship Program significantly contributes to improved knowledge acquisition, behavioral changes in practice, and positive impact on institutional systems. The evidence strongly supports the program's effectiveness as a vital educational resource for advancing the management of glomerular diseases.

Funding

  • Other NIH Support

Digital Object Identifier (DOI)